Heterogeneity of lower airway inflammation in children with severe-persistent asthma

Caitlin E O'Brien1, Kalliope Tsirilakis2, Maria Teresa Santiago2

  • 1Department of Pediatrics, Kravis Children's Hospital, Icahn School of Medicine at Mount Sinai, New York City, New York.

Pediatric Pulmonology
|March 6, 2015
PubMed

Insights

This study analyzed airway inflammation in children with severe-persistent asthma, finding neutrophilic inflammation most common. Further research is needed to link inflammation patterns to causes and guide personalized asthma treatments.

Area of Science:

  • Pediatric Pulmonology
  • Asthma Pathophysiology
  • Immunology

Background:

  • Severe-persistent asthma in children presents treatment challenges.
  • Inflammatory profiles may guide personalized asthma management strategies.
  • This study investigates airway inflammation patterns in pediatric severe asthma.

Purpose of the Study:

  • To characterize the inflammatory profile in bronchoalveolar lavage (BAL) fluid from children with severe-persistent asthma.
  • To compare these inflammatory profiles with serum IgE levels.
  • To identify potential patterns for improved asthma treatment.

Main Methods:

  • Retrospective analysis of BAL fluid from 32 children with severe-persistent asthma (Severe Asthma Research Program criteria).
  • Classification of inflammatory patterns: neutrophilic, eosinophilic, mixed, or pauci-granulocytic.
  • Measurement of serum total IgE and correlation with BAL inflammatory markers.

Main Results:

  • Neutrophilic inflammation was the most prevalent pattern (37.5%), followed by eosinophilic (28.1%), mixed (21.9%), and pauci-granulocytic (11.1%).
  • A significant correlation was found between serum IgE levels and BAL eosinophil percentages (P = 0.04).
  • An eosinophilic BAL pattern showed an odds ratio of 4.67 for elevated serum IgE (P = 0.12).

Conclusions:

  • This study highlights significant heterogeneity in lower airway inflammation in children with severe-persistent asthma.
  • Results indicate a higher prevalence of neutrophilic inflammation compared to some previous pediatric studies.
  • Further research is essential to determine if specific inflammatory patterns correlate with distinct etiologies and warrant individualized therapeutic approaches.
Abstract

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
5.0K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.4K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.8K